中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (5): 585-595.doi: 10.12092/j.issn.1009-2501.2026.05.002
魏宗烽(
), 谭金龙, 孙梦涵, 朱乃亮, 翟莹莹, 陈琼, 毕晶晶, 梁利香(
), 宋敏(
)
收稿日期:2025-06-09
修回日期:2025-09-03
出版日期:2026-05-26
发布日期:2026-06-02
通讯作者:
梁利香,宋敏
E-mail:21968611@qq.com;916912572@qq.com;1797405679@qq.com
作者简介:魏宗烽,男,硕士,副教授,研究方向:中药学。E-mail:基金资助:
Zongfeng WEI(
), Jinlong TAN, Menghan SUN, Nailiang ZHU, Yingying ZHAI, Qiong CHEN, Jingjing BI, Lixiang LIANG(
), Min SONG(
)
Received:2025-06-09
Revised:2025-09-03
Online:2026-05-26
Published:2026-06-02
Contact:
Lixiang LIANG,Min SONG
E-mail:21968611@qq.com;916912572@qq.com;1797405679@qq.com
摘要:
目的: 探讨法半夏治疗慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)的作用机制。方法: 将40只雄性C57BL/6J小鼠随机分为对照组(n=8)、模型组(n=12)、法半夏组(1.5 g/kg,n=12)和氨茶碱组(1 mg/kg,n=8)。采用烟熏联合脂多糖滴鼻法建立COPD小鼠模型。HE染色观察小鼠肺组织病理损伤,MASSON、MMP2和MMP9的免疫组化染色检测肺组织纤维化,α-SMA免疫组化染色检测肺组织成纤维细胞的转化,CD206和F4/80免疫组化染色检测肺组织M2巨噬细胞极化,qPCR检测TGF-β1和Arg-1基因表达,Western blot检测肺组织中Stat1、p-Stat1蛋白表达。此外,通过Transwell小室对巨噬细胞和成纤维细胞进行共培养,分为空白组、对照组、模型组、法半夏低、中、高剂量组(10、20、40 μg/mL),α-SMA免疫荧光检测成纤维细胞的转化。结果: 法半夏能明显减轻COPD损伤(P<0.01),抑制肺组织增生和纤维化(P<0.001),降低TGF-β1和Arg-1基因相对表达量(P<0.05),抑制成纤维细胞的转化(P<0.05),减少M2型巨噬细胞极化(P<0.05),增加p-Stat1/Stat1比率(P<0.05)。结论: 法半夏通过阻断巨噬细胞和成纤维细胞的Crosstalk改善COPD的纤维化进程,可能与法半夏激活Stat1通路抑制M2型巨噬细胞极化有关。
中图分类号:
魏宗烽, 谭金龙, 孙梦涵, 朱乃亮, 翟莹莹, 陈琼, 毕晶晶, 梁利香, 宋敏. 法半夏通过巨噬细胞和成纤维细胞的Crosstalk减轻COPD损伤机制研究[J]. 中国临床药理学与治疗学, 2026, 31(5): 585-595.
Zongfeng WEI, Jinlong TAN, Menghan SUN, Nailiang ZHU, Yingying ZHAI, Qiong CHEN, Jingjing BI, Lixiang LIANG, Min SONG. Mechanism study of Processed Pinellia ternata alleviating COPD injury through macrophages and fibroblasts Crosstalk[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(5): 585-595.
| Gene | Forward primer | Reward primer |
| TGF-β1 | ACTGGAGTTGTACGGCAGTG | GGGGCTGATCCCGTTGATTT |
| Arg-1 | AGCACTGAGGAAAGCTGGTC | TACGTCTCGCAAGCCAATGT |
| GAPDH | ACAGCAACAGGGTGGTGGAC | TTTGAGGGTGCAGCGAACTT |
表 1
Table 1 Primer sequences
| Gene | Forward primer | Reward primer |
| TGF-β1 | ACTGGAGTTGTACGGCAGTG | GGGGCTGATCCCGTTGATTT |
| Arg-1 | AGCACTGAGGAAAGCTGGTC | TACGTCTCGCAAGCCAATGT |
| GAPDH | ACAGCAACAGGGTGGTGGAC | TTTGAGGGTGCAGCGAACTT |
图 1
Fig.1 The effect of Processed Pinellia ternata on COPD ($\bar x $±s, n≥8) A: lung tissues photos in groups; B: lung/body weight ratio analysis. ***P<0.001, compared with control group; ##P<0.01, compared with model group.
图 2
Fig.2 The effect of Processed Pinellia ternata on lung tissue injury ($\bar x $±s, n=3) A: HE staining of alveoli in each group; B: HE staining of bronchi in each group; C-F: statistical analysis of WT%, WA%, smooth muscle thickness and bronchial wall thickness. ****P<0.001, compared with control group; ###P<0.001, compared with model group.
图 3
Fig.3 The effect of Processed Pinellia ternata on pulmonary fibrosis ($\bar x $±s, n=3) A-B: Alveolar Masson staining and fibrosis analysis in each group; C-D: Bronchi Masson staining and fibrosis analysis in each group; ***P<0.001, compared with control group; ###P<0.001, compared with model group.
图 4
Fig.4 The effect of Processed Pinellia ternata on the expression of MMP2 and MMP9 ($\bar x $±s, n=3) A-D: Immunohistochemical staining and quantitative analysis of MMP2 in the alveoli and bronchi of lung tissue; E-H: Immunohistochemical staining and quantitative analysis in the alveoli and bronchi of lung tissue; ***P<0.001, compared with control group; ###P<0.001, compared with model group.
图 5
Fig.5 The effect of Processed Pinellia ternata on fibroblast transformation in COPD model ($\bar x $±s, n=3) A-B: α-SMA immunohistochemical staining and quantitative analysis of alveolar in each group; C-D: α-SMA immunohistochemical staining and quantitative analysis of bronchi in each group; **P<0.01, compared with control group; #P<0.05, ##P<0.01, compared with model group.
图 6
Fig.6 Effect of Processed Pinellia ternata on fibroblast transformation in co-culture model ($\bar x $±s, n=3) A: Co-culure model establishment; B-C: α-SMA immunofluorescence staining and quantitative analysis of each group; ***P<0.001, compared with control group; ###P<0.001, compared with model group.
图 7
Fig.7 The effect of Processed Pinellia ternata on the expression of TGF-β1 and Arg-1 ($\bar x $±s, n=3) A-B: TGF-β1 and Arg-1 genes expression and quantitative analysis in the lung tissues. *P<0.05, ***P<0.001, compared with control group; #P<0.05, ##P<0.01, compared with model group.
图 8
Fig.8 The effect of Processed Pinellia ternata on M2 macrophages polarization ($\bar x $±s, n=3) A: F4/80 immunohistochemical staining in lung tissue; B: CD206 immunohistochemical staining in lung tissue; C: Quantitative analysis of CD206/F4/80 ratio. **P<0.01, compared with control group; #P<0.05, compared with model group.
图 9
Fig.9 The effect of Processed Pinellia ternata on the Stat1 signaling pathway ($\bar x $±s, n=3) A-B: expression levels and quantitative analysis of p-Stat1, Stat1 and β-actin in lung tissues. *P<0.05, compared with control group; #P<0.05, compared with model group.
| 1 |
Tanabe N, Nakagawa H, Sakao S, et al. Lung imaging in COPD and asthma[J]. Respir Investig, 2024, 62 (6): 995- 1005.
doi: 10.1016/j.resinv.2024.08.014 |
| 2 |
Christenson SA, Smith BM, Bafadhel M, et al. Chronic obstructive pulmonary disease[J]. Lancet, 2022, 399 (10342): 2227- 2242.
doi: 10.1016/S0140-6736(22)00470-6 |
| 3 |
Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue remodeling[J]. Eur Respir J, 2008, 31 (6): 1334- 1356.
doi: 10.1183/09031936.00018908 |
| 4 |
王胜, 陈永平, 吕敬龙, 等. 巨噬细胞来源的TGF-β对小鼠骨髓成纤维细胞增殖及Ⅰ型胶原表达的影响[J]. 中国免疫学杂志, 2020, 36 (12): 1437- 1440.
doi: 10.3969/j.issn.1000-484X.2020.12.006 |
| 5 | 赵芳哲, 桑晓青, 朱彦, 等. M2型巨噬细胞促分泌的IL-6因子对成纤维细胞活化的作用机制研究[J]. 药学学报, 2020, 55 (5): 892- 897. |
| 6 | 杨勤军, 韩明向, 韦利梅, 等. 慢性阻塞性肺疾病中医病因病机及证治规律探讨[J]. 中国实验方剂学杂志, 2023, 29 (18): 216- 222. |
| 7 |
Zou T, Wang J, Wu X, et al. A review of the research progress on Pinellia ternata (Thunb. ) Breit. : Botany, traditional uses, phytochemistry, pharmacology, toxicity and quality control[J]. Heliyon, 2023, 9 (11): e22153.
doi: 10.1016/j.heliyon.2023.e22153 |
| 8 | 彭加兵, 张凤, 陈丽娟. 半夏对慢性阻塞性肺疾病大鼠EGFR/ERK/Sp1/MUC5AC通路的影响[J]. 临床合理用药, 2025, 18 (7): 1- 5+9. |
| 9 |
Wu J, Jiang L, Wang S, et al. TGF β1 promotes the polarization of M2-type macrophages and activates PI3K/mTOR signaling pathway by inhibiting ISG20 to sensitize ovarian cancer to cisplatin[J]. Int Immunopharmacol, 2024, 134, 112235.
doi: 10.1016/j.intimp.2024.112235 |
| 10 |
Barnes PJ. Chronic obstructive pulmonary disease: effects beyond the lungs[J]. PLOS Med, 2017, 14 (3): e1002277.
doi: 10.1371/journal.pmed.1000220 |
| 11 |
Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2017 report: GOLD executive summary[J]. Am J Respir Crit Care Med, 2017, 195 (5): 557- 582.
doi: 10.1164/rccm.201701-0218PP |
| 12 |
Tashkin DP, Ferguson GT. Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease[J]. Respir Res, 2013, 14 (1): 49.
doi: 10.1186/1465-9921-14-49 |
| 13 |
Cazzola M, Page CP, Calzetta L, et al. Pharmacology and therapeutics of bronchodilators[J]. Pharmacol Rev, 2012, 64 (3): 450- 504.
doi: 10.1124/pr.111.004580 |
| 14 |
Wang MT, Lai JH, Tsai CL, et al. Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease[J]. J Food Drug Anal, 2019, 27 (3): 657- 670.
doi: 10.1016/j.jfda.2018.12.006 |
| 15 |
宫海艳, 温海艳, 姜莉. 慢性阻塞性肺疾病合并肺间质纤维化的临床分析[J]. 中国医科大学学报, 2013, 42 (3): 262- 263.
doi: 10.3969/j.issn.0258-4646.2013.03.018 |
| 16 | 刘晓明, 张伟. 论慢性阻塞性肺疾病合并肺纤维化的病因病机[J]. 中国中医基础医学杂志, 2016, 22 (11): 1463- 1464. |
| 17 |
Craig VJ, Zhang L, Hagood JS, et al. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis[J]. Am J Respir Cell Mol Biol, 2015, 53 (5): 585- 600.
doi: 10.1165/rcmb.2015-0020TR |
| 18 |
Zhang Y, Li Y, Ye Z, et al. Expression of matrix metalloproteinase-2, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and changes in alveolar septa in patients with chronic obstructive pulmonary disease[J]. Med Sci Monit, 2020, 26, e925278.
doi: 10.12659/msm.925278 |
| 19 | 谭明娜, 易兴亮, 杨锐, 等. 基于MMP-9/TIMP-1失衡理论探讨玉屏风散对肺气虚型慢性阻塞性肺疾病大鼠气道炎症和气道重塑的影响及机制[J]. 中国老年学杂志, 2024, 44 (24): 6055- 6060. |
| 20 |
张胜碧, 刘燕玲, 李岚. 地龙提取液对卵清蛋白诱导哮喘小鼠气道重塑及肺组织MMP2、MMP9、TIMP-1表达的影响[J]. 中国新药与临床杂志, 2021, 40 (7): 523- 530.
doi: 10.14109/j.cnki.xyylc.2021.07.10 |
| 21 |
李爱琴, 张震, 徐雅楠, 等. 急性呼吸窘迫综合征肺纤维化中巨噬细胞和成纤维细胞相互作用的研究进展[J]. 实用医学杂志, 2024, 40 (4): 571- 574.
doi: 10.3969/j.issn.1006-5725.2024.04.023 |
| 22 |
Chen S, Morine Y, Tokuda K, et al. Cancer-associated fibroblast-induced M2-polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor-1 pathway[J]. Int J Oncol, 2021, 59 (2): 59.
doi: 10.3892/ijo.2021.5239 |
| 23 |
Feng P, Che Y, Gao C, et al. Profibrotic role of transcription factor SP1 in cross-talk between fibroblasts and M2 macrophages[J]. iScience, 2023, 26 (12): 108484.
doi: 10.1016/j.isci.2023.108484 |
| 24 |
靳庆瑞, 边汝涛, 徐学功. 成纤维细胞与巨噬细胞交互作用在心肌纤维化中的研究进展[J]. 中华老年心脑血管病杂志, 2025, 27 (3): 389- 391.
doi: 10.3969/j.issn.1009-0126.2025.03.030 |
| 25 | Yang J, Zhang L, Yu C, et al. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases[J]. Biomark Res, 2022, 10 (1): 86. |
| 26 | Hou J, Shi J, Chen L, et al. M2 macrophages promote myofibroblast differentiation of LR-MSCs and are associated with pulmonary fibrogenesis[J]. Cell Commun Signal, 2022, 20 (1): 1- 15. |
| 27 |
Yang S, Liu P, Jiang Y, et al. Therapeutic applications of mesenchymal stem cells in idiopathic pulmonary fibrosis[J]. Front Cell Dev Biol, 2021, 9, 639657.
doi: 10.3389/fcell.2021.639657 |
| 28 | Hu X, Li J, Fu M, et al. The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective?[J]. Arthritis Res Ther, 2021, 23 (1): 159. |
| 29 |
Yang J, Li L, Wang L, et al. Trophoblast-derived miR-410-5p induces M2 macrophage polarization and mediates immunotolerance at the fetal-maternal interface by targeting the STAT1 signaling pathway[J]. J Transl Med, 2024, 22 (1): 19.
doi: 10.1186/s12967-023-04831-y |
| 30 |
Liu S, Gong H, Li P, et al. Chemotherapy-induced macrophage CXCL7 expression drives tumor chemoresistance via the STAT1/PHGDH-serine metabolism axis and SAM paracrine feedback to M2 polarization[J]. Cell Death Dis, 2025, 16 (1): 379.
doi: 10.1038/s41419-025-07712-y |
| [1] | 李群, 张馨月, 祁硕, 谭劲. TGF-β1/Smads信号通路在口腔黏膜下纤维化中的作用机制及中药调控研究进展[J]. 中国临床药理学与治疗学, 2026, 31(5): 666-674. |
| [2] | 杨浩东, 李龙, 罗敬轩, 李静蕾. Hippo通路效应因子YAP/TAZ在特发性肺纤维化中的研究进展[J]. 中国临床药理学与治疗学, 2026, 31(5): 709-715. |
| [3] | 张佳娴, 肖坚, 黄行行, 李梦瑶, 鱼婷, 于慧敏, 李靖阳, 宁磊, 王莹. 慢性阻塞性肺疾病门诊患者的药物相关问题及其相关因素:一项横断面回顾性研究[J]. 中国临床药理学与治疗学, 2026, 31(4): 474-485. |
| [4] | 白雅洁, 杨柳青, 范钦, 刘旭玮, 何雨宸, 成家茂, 陈海燕. 铁皮石斛多糖通过上皮间质转化和Notch信号通路体外抗肝纤维化作用机制[J]. 中国临床药理学与治疗学, 2026, 31(3): 337-343. |
| [5] | 黄元嫄, 王令谆. 中医药调控信号通路干预心肌纤维化研究进展[J]. 中国临床药理学与治疗学, 2026, 31(3): 372-381. |
| [6] | 汪涛, 程筱雯, 张智瑞, 焦浩. 紫草素抑制TGF-β1/Smad信号通路改善小鼠肾纤维化的实验研究[J]. 中国临床药理学与治疗学, 2026, 31(1): 48-54. |
| [7] | 李蒙雨, 江伟, 张亚飞, 潘欣, 王媛媛. 上皮细胞和巨噬细胞相互作用在肺部疾病中的研究进展[J]. 中国临床药理学与治疗学, 2025, 30(9): 1253-1259. |
| [8] | 刘寻, 周婷婷, 朱紫冰, 谭劲, 李群. 槟榔碱通过上调PI3K/Akt/mTOR信号通路促进口腔黏膜下纤维化的体内外实验研究[J]. 中国临床药理学与治疗学, 2025, 30(7): 865-875. |
| [9] | 林婧怡, 韩壤乐, 徐玲慧, 谭睿陟, 粟宏伟, 王丽. 黄芪三七合剂抑制lncRNA Gm51500/Adam12轴改善CKD肾脏纤维化[J]. 中国临床药理学与治疗学, 2025, 30(6): 750-762. |
| [10] | 李明奇, 王映荷, 赵晓璐, 包小妹, 岳鑫, 任贵强, 马月宏. 基于LC-MS/MS结合网络药理学、分子对接及体内外实验探究红花总黄酮抗肝纤维化的作用机制[J]. 中国临床药理学与治疗学, 2025, 30(5): 586-598. |
| [11] | 杨冬梨, 李静, 段丽芳, 张文将, 李娜, 张红. 氧化应激相关调控蛋白Cygb抗纤维化作用的研究进展[J]. 中国临床药理学与治疗学, 2025, 30(5): 683-689. |
| [12] | 李雯, 蒋虎刚, 王新强, 李应东, 刘凯, 赵信科. 当归黄芪超滤物介导Jagged1/Notch1通路抑制成纤维细胞转分化抗放射性心肌纤维化的作用机制研究[J]. 中国临床药理学与治疗学, 2025, 30(2): 209-215. |
| [13] | 李慧, 胡恒钊, 俞婷婷, 胡慧娴, 王佳乐, 吴晶, 郝伟. 白花丹素通过调节TGF-β1/Smad2及Nrf2/NOX4通路改善博来霉素诱导的肺纤维化[J]. 中国临床药理学与治疗学, 2025, 30(1): 61-69. |
| [14] | 倪姐, 洪小丹, 计可, 贾元威, 王广基, 张经纬. 乙肝合并肝纤维化对内外源性代谢的影响及治疗学启示[J]. 中国临床药理学与治疗学, 2024, 29(8): 853-860. |
| [15] | 吴笑雪, 叶益平, 雷振东, 张尊敬, 陈文霖. 淫羊藿苷通过Cx32-Nox4信号通路改善高血压肾纤维化和损伤[J]. 中国临床药理学与治疗学, 2024, 29(8): 870-878. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||